Next Article in Journal
Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future
Next Article in Special Issue
Diagnosis and Management of Merkel Cell Carcinoma of the Head and Neck: Current Trends and Controversies
Previous Article in Journal
Updates and Controversies in the Rapidly Evolving Field of Lung Cancer Screening, Early Detection, and Chemoprevention
Previous Article in Special Issue
Merkel Cell Carcinoma of the Eyelid and Periocular Region
Cancers 2014, 6(2), 1180-1194; doi:10.3390/cancers6021180
Review

Systemic Therapy for Merkel Cell Carcinoma: What’s on the Horizon?

Received: 27 February 2014 / Revised: 8 May 2014 / Accepted: 9 May 2014 / Published: 16 May 2014
(This article belongs to the Special Issue Merkel Cell Carcinoma)
View Full-Text   |   Download PDF [561 KB, uploaded 16 May 2014]

Abstract

Merkel cell carcinoma is an aggressive neuroendocrine skin cancer that usually affects elderly patients. Despite being uncommon, incidence has been steadily increasing over the last two decades, likely due to increased awareness, better diagnostic methods and aging of the population. It is currently one of the most lethal cutaneous malignancies, with a five-year overall survival of approximately 50%. With the better understanding of the molecular pathways that lead to the development of Merkel cell carcinoma, there has been an increasing excitement and optimism surrounding novel targeted therapies, in particular to immunotherapy. Some of the concepts surrounding the novel targeted therapies and currently ongoing clinical trials are reviewed here.
Keywords: Merkel cell carcinoma; merkel cell polyomavirus; immunotherapy; targeted therapy Merkel cell carcinoma; merkel cell polyomavirus; immunotherapy; targeted therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Rabinowits, G. Systemic Therapy for Merkel Cell Carcinoma: What’s on the Horizon? Cancers 2014, 6, 1180-1194.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert